S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.

3570 Background: The ACTS-CC trial, a randomized phase III trial, demonstrated that adjuvant therapy with S-1 for stage III colon cancer was non-inferior in 3-year disease-free survival (DFS) to th...